Antibody & mRNA Drugs
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
38
NCT05687682
Safety of AM-928 Infusion in Advanced Solid Tumors
Phase: Phase 1
Role: Lead Sponsor
Start: Jul 14, 2023
Completion: Jun 30, 2026
Loading map...